January 22, 2025
Breaking Barriers: How DSCSA Transforms Healthcare Supply Chains
Gary Lerner, Founder and President of Gateway Checker, was recently a guest on the Next Level Supply Chain Podcast by GS1 US. Speaking with VP of Innovation and Partnerships at GS1 US, Reid Jackson, their discussion highlighted the importance of a secure supply chain in keeping healthcare patients safe. Their conversation covers the Drug Supply […]
January 17, 2025
Conversation with GS1 to be Released January 22nd – Next Level Supply Chain Podcast
Gateway Checker founder and president Gary Lerner recently had the opportunity to speak on the Next Level Supply Chain Podcast, hosted by GS1 US. His conversation focused on DSCSA guidelines and their benefits on the supply chain, best practices for conformance, and tons more. The episode will be released on January 22nd—to watch […]
January 10, 2025
PBM Legislation – Exempt from Government Spending Bill
Reform Will Have to Wait In dramatic fashion, previously anticipated reform centered around pharmacy benefit managers was not a part of Congress’s end-of-year spending bill. As mentioned in my last post, this PBM reform included a ban on spread pricing and de-linking PBM fees from the list price. Advocates for reform emphasize how these measures […]
December 19, 2024
Pharmacy Benefit Manager Legislation and the Impact on the Pharma Supply Chain
The Cost of PBMs Last week, Senator Elizabeth Warren (D-Massachusetts) and Josh Hawley (R-Missouri) introduced a bill requiring healthcare companies that own health insurers or pharmacy benefit managers (PBMs) to sell pharmacy assets within three years. If this legislation were to pass, it would significantly impact the pharmaceutical supply chain and perhaps help to control […]
December 11, 2024
Trump’s Tariffs and Drug Prices
Following his election victory, president-elect Donald Trump announced intentions of implementing tariffs on Canada, Mexico, and China; these tariffs include 25% tax on imports from both Mexico and Canada, and an additional 10% increase on the tariffs already in place on Chinese exports to the United States. The goals of these imports, according to the […]
